ENTRY       K04707                      KO
NAME        CBL
DEFINITION  E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
PATHWAY     ko04012  ErbB signaling pathway
            ko04120  Ubiquitin mediated proteolysis
            ko04144  Endocytosis
            ko04630  Jak-STAT signaling pathway
            ko04660  T cell receptor signaling pathway
            ko04910  Insulin signaling pathway
            ko05100  Bacterial invasion of epithelial cells
            ko05200  Pathways in cancer
            ko05205  Proteoglycans in cancer
            ko05220  Chronic myeloid leukemia
DISEASE     H00523  Noonan syndrome and related disorders
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Genetic Information Processing
              Folding, sorting and degradation
               04120 Ubiquitin mediated proteolysis
                K04707  CBL; E3 ubiquitin-protein ligase CBL
             Environmental Information Processing
              Signal transduction
               04012 ErbB signaling pathway
                K04707  CBL; E3 ubiquitin-protein ligase CBL
               04630 Jak-STAT signaling pathway
                K04707  CBL; E3 ubiquitin-protein ligase CBL
             Cellular Processes
              Transport and catabolism
               04144 Endocytosis
                K04707  CBL; E3 ubiquitin-protein ligase CBL
             Organismal Systems
              Immune system
               04660 T cell receptor signaling pathway
                K04707  CBL; E3 ubiquitin-protein ligase CBL
              Endocrine system
               04910 Insulin signaling pathway
                K04707  CBL; E3 ubiquitin-protein ligase CBL
             Human Diseases
              Cancers
               05200 Pathways in cancer
                K04707  CBL; E3 ubiquitin-protein ligase CBL
               05205 Proteoglycans in cancer
                K04707  CBL; E3 ubiquitin-protein ligase CBL
               05220 Chronic myeloid leukemia
                K04707  CBL; E3 ubiquitin-protein ligase CBL
              Infectious diseases
               05100 Bacterial invasion of epithelial cells
                K04707  CBL; E3 ubiquitin-protein ligase CBL
            Enzymes [BR:ko01000]
             6. Ligases
              6.3  Forming carbon-nitrogen bonds
               6.3.2  Acid-D-amino-acid ligases (peptide synthases)
                6.3.2.19  ubiquitin---protein ligase
                 K04707  CBL; E3 ubiquitin-protein ligase CBL
            Ubiquitin system [BR:ko04121]
             Ubiquitin ligases (E3)
              single Ring-finger type E3
               CBL protein
                K04707  CBL; E3 ubiquitin-protein ligase CBL
GENES       HSA: 23624(CBLC) 867(CBL) 868(CBLB)
            PTR: 451690(CBL) 456117(CBLC) 460566(CBLB)
            PPS: 100984607(CBLB) 100988815(CBL) 100995637(CBLC)
            GGO: 101124684(CBLB) 101134347(CBLC) 101140325(CBL)
            PON: 100446187(CBLC) 100452289(CBLB) 100462634(CBL)
            MCC: 703879 704311(CBL) 713112(CBLC)
            MCF: 102114949(CBLB) 102135911(CBLC) 102137660(CBL)
            MMU: 12402(Cbl) 208650(Cblb) 80794(Cblc)
            RNO: 171136(Cblb) 292699(Cblc) 500985(Cbl)
            CGE: 100751369(Cblc) 100754737(Cbl) 100774600(Cblb)
            HGL: 101710004(Cbl) 101713714(Cblc) 101719173(Cblb)
            TUP: 102469580(CBL) 102485272(CBLB) 102487610(CBLC)
            CFA: 487965(CBLB) 489369(CBL) 612343(CBLC)
            AML: 100470573(CBL) 100473515(CBLB) 100478173(CBLC)
            FCA: 101095782(CBLC) 101096508(CBL) 101101498(CBLB)
            PTG: 102960753(CBL) 102962133(CBLB) 102962448(CBLC)
            BTA: 525906(CBLB) 527418(CBL) 615866(CBLC)
            BOM: 102279176(CBL) 102285545(CBLC) 102287221(CBLB)
            PHD: 102317029(CBLB) 102324329(CBLC) 102324436(CBL)
            CHX: 102185385(CBL) 102186998(CBLB) 102187397(CBLC)
            SSC: 100511697(CBLC) 100518854(CBL) 100621690(CBLB)
            CFR: 102504124(CBL) 102508318(CBLC) 102515465(CBLB)
            BACU: 103002776(CBLB) 103003237(CBLC) 103016132(CBL)
            LVE: 103069946(CBLC) 103082495(CBL) 103083966(CBLB)
            ECB: 100061819(CBLB) 100071403(CBL) 100147299(CBLC)
            MYB: 102240403(CBLC) 102242908(CBL) 102245043 102245653
            MYD: 102759944(CBLB) 102761297(CBLC) 102763080(CBL)
            PALE: 102884917(CBLC) 102890283(CBLB) 102895335(CBL)
            MDO: 100011932(CBLB) 100023698(CBLC) 100031184(CBL)
            SHR: 100913401(CBLB) 100918278(CBLC) 100920890(CBL)
            OAA: 100089052(CBLB) 100091424
            GGA: 374038(CBL) 418406(CBLB)
            MGP: 100546892 100549952
            TGU: 100226776(CBLB) 100227293(CBL)
            FAB: 101810639(CBL) 101810847(CBLB)
            PHI: 102103093(CBL) 102103800(CBLB)
            APLA: 101789789 101799051(CBLB)
            FPG: 101912806(CBLB) 101919050(CBL)
            FCH: 102053933(CBLB) 102058724(CBL)
            CLV: 102096530(CBL) 102097605(CBLB)
            ASN: 102372644(CBL) 102384451(CBLB)
            AMJ: 102563760(CBL) 102572063(CBLB)
            PSS: 102450818(CBL) 102454526(CBLB)
            CMY: 102937369(CBL) 102943844(CBLB)
            ACS: 100552102 100561034(cblb) 100568145
            PBI: 103056422(CBL) 103059707(CBLB) 103066304 103067394
            XLA: 431829(cblb-b) 443854(cblb-a)
            XTR: 448509(cblb) 594900(cbl)
            DRE: 492364(cbl) 556277(cblb) 565383(si:ch211-175g6.9)
            TRU: 101063765 101070370 101078613
            MZE: 101465135 101468920 101471367 101484242 101484693 101486978
            OLA: 101157475 101158476 101163758 101170289
            XMA: 102233950 102234614 102237712
            LCM: 102345712(CBL) 102346401 102349292 102358138
            CMK: 103172728 103180132(cblb) 103191373
            BFO: BRAFLDRAFT_60082
            CIN: 100176362
            SPU: 583481 765032
            DME: Dmel_CG7037(Cbl)
            DPO: Dpse_GA20050
            DAN: Dana_GF24399 Dana_GF25100
            DER: Dere_GG14313
            DPE: Dper_GL24706
            DSI: Dsim_GD14094
            DWI: Dwil_GK18041
            DYA: Dyak_GE20742
            DGR: Dgri_GH15065
            DMO: Dmoj_GI12833
            DVI: Dvir_GJ12975
            AGA: AgaP_AGAP005449
            AAG: AaeL_AAEL009739
            CQU: CpipJ_CPIJ012193
            AME: 411982(GB16551)
            NVI: 100119672
            BMOR: 101740182
            API: 100159071
            PHU: Phum_PHUM394550
            ISC: IscW_ISCW019991
            CEL: CELE_M02A10.3(sli-1)
            CBR: CBG08124(Cbr-sli-1)
            BMY: Bm1_05660
            LOA: LOAG_05836
            TSP: Tsp_01088
            SMM: Smp_005020
            HMG: 100208241
            TAD: TRIADDRAFT_23727
            MBR: MONBRDRAFT_36983
REFERENCE   PMID:19689429
  AUTHORS   Wehrle C, Van Slyke P, Dumont DJ
  TITLE     Angiopoietin-1-induced ubiquitylation of Tie2 by c-Cbl is required for internalization and degradation.
  JOURNAL   Biochem J 423:375-80 (2009)
REFERENCE   PMID:11087752
  AUTHORS   Fang D, Wang HY, Fang N, Altman Y, Elly C, Liu YC
  TITLE     Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.
  JOURNAL   J Biol Chem 276:4872-8 (2001)
REFERENCE   PMID:10514377
  AUTHORS   Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC
  TITLE     The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.
  JOURNAL   Science 286:309-12 (1999)
REFERENCE   PMID:10086340
  AUTHORS   Ettenberg SA, Keane MM, Nau MM, Frankel M, Wang LM, Pierce JH, Lipkowitz S
  TITLE     cbl-b inhibits epidermal growth factor receptor signaling.
  JOURNAL   Oncogene 18:1855-66 (1999)
///
